PFSCF Stock UPDATES Prometic Life Scienc (PFSCF) 1.3980 08/28/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Prometic Life Scienc (PFSCF) 1.3980 $PFSCF

ProMetic Reports its Second Quarter 2014 Highlights and Financial Results
Marketwire - Thu Aug 14, 3:02PM CDT
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) ("ProMetic" or the "Corporation" today reported revenues of $4.4 million and a net profit of $23.4 million for the second quarter ended June 30, 2014 resulting from the recognition of a gain on revaluation of the equity investment of ProMetic's equity interest in NantPro.

ProMetic to Report its Second Quarter 2014 Financial Results and Hold Conference Call / Webcast
Marketwire - Mon Aug 11, 11:35AM CDT
ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" or the "Corporation" today announced that it will report its financial results for the second quarter ended June 30, 2014 on Thursday August 14, 2014 after market hours.

ProMetic Secures $20 Million Follow-on Investment from Thomvest Seed Capital Inc.
Marketwire - Fri Aug 01, 7:18AM CDT
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) ("ProMetic" or the "Corporation" announced today that it has secured a follow-on investment from Thomvest Seed Capital Inc. ("Thomvest" , the Toronto-based investment vehicle of Peter J. Thomson, consisting of a $20 million Loan. As partial consideration for the Loan, ProMetic has granted Thomvest 16,723,807 warrants with an exercise price of $1.87 per common share, a premium of 52% to yesterday's closing share price.

ProMetic Enters Into New Product Program With an Existing Multinational Client
Marketwire - Thu Jul 24, 7:40AM CDT
July 24, 2014 - ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation" announced today the signing of an agreement (the "Agreement" by ProMetic's UK subsidiary, ProMetic Biosciences Ltd ("PBL" , with one of its existing multinational clients, a global leader in the biotherapeutics industry.

ProMetic to Commercially Launch Fibrinogen in the Fourth Quarter of 2014
Marketwire - Thu Jul 10, 7:09AM CDT
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation" announced today that it will launch fibrinogen for commercial sales during the fourth quarter of 2014 after its successful scale-up at its Laval based plasma purification facility, ProMetic BioProduction Inc. ("PBP" . This follows the previously disclosed proteins already scheduled for production at PBP, namely plasminogen, IVIG and Alpha-1 Antitrypsin.

ProMetic Successfully Completes its PBI-4050 Phase I Clinical Trial
Marketwire - Wed Jun 18, 5:01AM CDT
ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF), ("ProMetic" or the "Corporation" reported today that it has successfully completed its PBI-4050 Phase I clinical trial in 40 healthy volunteers. ProMetic's PBI-4050 was found to be safe and very well tolerated without any serious adverse events reported in any of the 5 cohorts tested.

ProMetic Reports Successful Pre-IND Meeting with the FDA
Marketwire - Wed Apr 02, 6:02AM CDT
ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" or the "Corporation" announced today that it had a successful Pre-Investigational New Drug ("Pre-IND) meeting with the US Food and Drug Administration ("FDA" for a plasma-derived biopharmaceutical currently under development under the NantPro, LLC joint venture.

ProMetic Reports its 2013 Fourth Quarter and Financial Year End Results and Business Highlights
Marketwire Canada - Wed Mar 26, 4:11PM CDT
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX FSCF) ("ProMetic" or the "Corporation" today reported revenues of $5.1 million and $20.6 million for the quarter and year ended December 31, 2013 respectively. This compares to revenues of $8.3 million and $23.3 million for the quarter and year ended December 31, 2012 respectively.

ProMetic to Report its Fourth Quarter and Year End 2013 Financial Results and Hold Conference Call/Webcast
Marketwire - Fri Mar 21, 11:55AM CDT
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) ("ProMetic" or the "Corporation" today announced that it will report its financial results for the fourth quarter and fiscal year ended December 31, 2013 on Wednesday March 26, 2014 after market trading hours.

ProMetic Receives $3.2 Million Via Loan Repayment
Marketwire - Tue Mar 11, 5:31AM CDT
ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF), ("ProMetic" or the "Corporation" announced today that it has received approximately $3.2 million via the repayment of the amended and restated loan entered into in March, 2010 by ProMetic and InvHealth Holding Inc. ("Invhealth" , a corporation wholly-owned and controlled by Mr. Pierre Laurin, President and Chief Executing Officer of ProMetic (the "Loan" .




Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 13

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 243

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 139

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 11

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 176

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 464

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 39

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 82

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
Keiki Smiles Boosts Pediatric Dental Care in Waipahu

Updated Category News Views 43

A Neighborhood Dentists' Big Move: Keiki Smiles Expands in Waipahu Well, if there's one thing the dentists of Waipahu know how to do, it's adapt and grow. Keiki Smiles of Leeward, a trusted name in pediatric dentistry, just set up shop at a fresh location. The move marks a new chapter for this community staple, and honestly, it's miles more than just a longer lease and a...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 74

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading

Top 5 Most Recently Viewed Articles

Topicus.com Reports Q3 2025 Financial Results with Growth

Updated Category News Views 757

Financial Overview of Topicus.com Inc. for Q3 2025 In a significant financial announcement, Topicus.com Inc. (TSXV: TOI), in conjunction with Constellation Software Inc. (TSX: CSU), has shared their results for the third quarter of 2025. For the quarter ending on September 30, 2025, the total revenue reached €387.9 million, which reveals an impressive 24% increase from...

Continue Reading
First Financial Security, Inc. Executes a Strategic 10-for-1 Stock Split

Updated Category News Views 266

Strategic 10-for-1 Stock Split Announcement by First Financial Security, Inc. First Financial Security, Inc. (FFS) has recently announced a significant corporate action — a 10-for-1 stock split of its authorized shares of common stock. This adjustment is a clear indication of the company’s positive growth outlook and its unwavering commitment to providing enhanced...

Continue Reading
Octopus AIM VCT plc Reports Strong Net Asset Value Update

Updated Category News Views 55

Overview of Octopus AIM VCT plc Octopus AIM VCT plc is a distinguished investment firm known for its focus on investments in AIM-listed companies. The firm aims to provide investors with significant returns through its carefully managed portfolio, making it a key player in the investment landscape. With a commitment to transparency and value, Octopus AIM VCT plc regularly...

Continue Reading
Revolt CBD Shows Innovation and Growth in Its Latest Update

Updated Category News Views 180

Revolt CBD Launches Innovative Website Redesign In a significant move towards enhancing customer engagement, Revolt CBD has officially unveiled its newly redesigned website. This development marks a pivotal moment for the brand as it strives to improve accessibility, transparency, and innovation in 2026. The new online platform is designed to better reflect the brand's...

Continue Reading
Strategic Merger to Enhance Biopharmaceutical Innovations

Updated Category News Views 86

Exciting Merger Between ACELYRIN and Alumis The proposed merger between ACELYRIN, INC. (Nasdaq: SLRN) and Alumis Inc. marks a pivotal moment in the biopharma landscape focused on immune-mediated diseases. This partnership is set to create a robust clinical stage company, combining strengths and resources to deliver transformative treatment options to patients. Key...

Continue Reading